Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Sees Large Decline in Short Interest

by · The Cerbat Gem

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW – Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 19,294 shares, a decrease of 19.8% from the November 30th total of 24,046 shares. Based on an average daily volume of 21,064 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily volume of 21,064 shares, the days-to-cover ratio is currently 0.9 days.

Coeptis Therapeutics Price Performance

COEPW traded down $0.00 during midday trading on Wednesday, reaching $0.01. 23,306 shares of the company were exchanged, compared to its average volume of 59,893. Coeptis Therapeutics has a one year low of $0.00 and a one year high of $0.06. The stock’s 50-day simple moving average is $0.02 and its 200 day simple moving average is $0.02.

Coeptis Therapeutics Company Profile

(Get Free Report)

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.

Featured Stories